Practical Considerations in Convalescent Plasma Therapy for Coronavirus Disease 2019
10.17945/kjbt.2020.31.1.67
- Author:
Juhye ROH
1
;
Hyun Mi KIM
;
Jun Nyun KIM
;
Sinyoung KIM
;
Hyun Ok KIM
Author Information
1. Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea
- Publication Type:Letters to the Editor
- From:Korean Journal of Blood Transfusion
2020;31(1):67-69
- CountryRepublic of Korea
-
Abstract:
Convalescent plasma therapy has been used to achieve passive immunization against diverse infectious agents by administering pathogen-specific antibodies. Coronavirus disease 19 (COVID-19), which originated in Wuhan, China, has recently become a major concern all over the world. There are no specific treatment recommendations for COVID-19 because of the lack of knowledge and evidence about this virus. Convalescent plasma therapy can be used as an empirical and investigational treatment for COVID-19, and so we briefly describe the main issues related to convalescent plasma therapy from the perspective of transfusion medicine.
